Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
SIGMAPHARM, INC. v. MUTUAL PHARMACEUTICAL COMPANY, INC. et al
Case Number:
2:12-cv-02522
Court:
Nature of Suit:
Other Statutes: Racketeer/Corrupt Organization
Judge:
Firms
Companies
Sectors & Industries:
-
July 16, 2013
SigmaPharm Gets Skelaxin Suit Sent Back To Pa. Court
A Pennsylvania federal judge Tuesday remanded to state court SigmaPharm Inc.'s lawsuit accusing Mutual Pharmaceutical Co. Inc. and others of conspiring to suppress the release of generic forms of muscle relaxant Skelaxin, ruling she lacked jurisdiction over the case, which only asserts state law claims.
-
October 31, 2012
SigmaPharm Looks To Relaunch Skelaxin Antitrust Battle
SigmaPharm Inc. on Wednesday sought a fresh start in its long-running antitrust fight with King Pharmaceuticals Inc. and Mutual Pharmaceutical Co. Inc., which it accuses of masterminding a conspiracy to suppress the release of generic forms of the muscle relaxer Skelaxin and to rob it of millions in royalties.